Evaxion Biotech A/S Quarterly Liabilities in USD from Q4 2019 to Q4 2023

Taxonomy & unit: ifrs-full: USD
Summary: Evaxion Biotech A/S quarterly Liabilities history and growth rate from Q4 2019 to Q4 2023.
Evaxion Biotech A/S Liabilities for the quarter ending December 31, 2023 was $17.6M, a 28.4% increase year-over-year.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$17.6M	+$3.9M	+28.4%	Dec 31, 2023	20-F	2024-03-26
Q2 2023	$14.2M	+$365K	+2.64%	Jun 30, 2023	6-K	2023-08-17
Q4 2022	$13.7M	+$6M	+77.6%	Dec 31, 2022	20-F	2024-03-26
Q2 2022	$13.9M	+$8.03M	+138%	Jun 30, 2022	6-K	2022-08-11
Q1 2022	$14.7M	+$7.57M	+106%	Mar 31, 2022	6-K	2022-05-12
Q4 2021	$7.73M	+$2.8M	+56.8%	Dec 31, 2021	20-F	2023-04-28
Q3 2021	$7.47M			Sep 30, 2021	6-K	2021-11-10
Q2 2021	$5.83M			Jun 30, 2021	6-K	2021-08-13
Q1 2021	$7.12M			Mar 31, 2021	6-K	2021-05-14
Q4 2020	$4.93M	+$3.21M	+186%	Dec 31, 2020	20-F	2022-03-31
Q4 2019	$1.72M			Dec 31, 2019	20-F	2021-04-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.